|
1
|
Pui CH, Relling MV and Downing JR: Acute
lymphoblastic leukemia. N Engl J Med. 350:1535–1548. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mody R, Li S, Dover DC, Sallan S,
Leisenring W, Oeffinger KC, Yasui Y, Robison LL and Neglia JP:
Twenty-five-year follow-up among survivors of childhood acute
lymphoblastic leukemia: A report from the childhood cancer survivor
study. Blood. 111:5515–5523. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chiaretti S and Foà R: T-cell acute
lymphoblastic leukemia. Haematologica. 94:160–162. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ferrando AA, Neuberg DS, Staunton J, Loh
ML, Huard C, Raimondi SC, Behm FG, Pui CH, Downing JR, Gilliland
DG, et al: Gene expression signatures define novel oncogenic
pathways in T cell acute lymphoblastic leukemia. Cancer Cell.
1:75–87. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Roberts KG and Mullighan CG: Genomics in
acute lymphoblastic leukaemia: Insights and treatment implications.
Nat Rev Clin Oncol. 12:344–357. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Neumann M, Vosberg S, Schlee C, Heesch S,
Schwartz S, Gökbuget N, Hoelzer D, Graf A, Krebs S, Bartram I, et
al: Mutational spectrum of adult T-ALL. Oncotarget. 6:2754–2766.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xu B, Teng LH, Silva SD, Bijian K, Al
Bashir S, Jie S, Dolph M, Alaoui-Jamali MA and Bismar TA: The
significance of dynamin 2 expression for prostate cancer
progression, prognostication, and therapeutic targeting. Cancer
Med. 3:14–24. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Razidlo GL, Wang Y, Chen J, Krueger EW,
Billadeau DD and McNiven MA: Dynamin 2 potentiates invasive
migration of pancreatic tumor cells through stabilization of the
Rac1 GEF Vav1. Dev Cell. 24:573–585. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chircop M, Perera S, Mariana A, Lau H, Ma
MP, Gilbert J, Jones NC, Gordon CP, Young KA, Morokoff A, et al:
Inhibition of dynamin by dynole 34-2 induces cell death following
cytokinesis failure in cancer cells. Mol Cancer Ther. 10:1553–1562.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Neumann M, Heesch S, Schlee C, Schwartz S,
Gökbuget N, Hoelzer D, Konstandin NP, Ksienzyk B, Vosberg S, Graf
A, et al: Whole-exome sequencing in adult ETP-ALL reveals a high
rate of DNMT3A mutations. Blood. 121:4749–4752. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Guo X, Zhang R, Liu J, Li M, Song C, Dovat
S, Li J and Ge Z: Characterization of LEF1 high expression and
novel mutations in adult acute lymphoblastic leukemia. PLoS One.
10:e01254292015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Parsons DW, Li M, Zhang X, Jones S, Leary
RJ, Lin JC, Boca SM, Carter H, Samayoa J, Bettegowda C, et al: The
genetic landscape of the childhood cancer medulloblastoma. Science.
331:435–439. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lin ZK, Zhang R, Ge Z, Liu J, Guo X, Qiao
C, Wu YJ, Qiu HR, Zhang JF and Li JY: Characteristics of NOTCH1
mutation in adult T-cell acute lymphoblastic leukemia. Zhongguo Shi
Yan Xue Ye Xue Za Zhi. 21:1403–1408. 2013.(In Chinese). PubMed/NCBI
|
|
14
|
Guo X, Zhang R, Ge Z, Xu JY, Li M, Qiao C,
Qiu HR and Li JY: Mutations of FBXW7 in adult T-cell acute
lymphocytic leukemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi.
23:612–618. 2015.(In Chinese). PubMed/NCBI
|
|
15
|
Wang Q, Qiu H, Jiang H, Wu L, Dong S, Pan
J, Wang W, Ping N, Xia J, Sun A, et al: Mutations of PHF6 are
associated with mutations of NOTCH1, JAK1 and rearrangement of
SET-NUP214 in T-cell acute lymphoblastic leukemia. Haematologica.
96:1808–1814. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shaffer LG, Slovak ML and Campbell LJ: An
International System for Human Cytogenetic
NomenclatureRecommendations of the International Standing Committee
on Human Cytogenetic Nomenclature. Karger; Basel, Switzerland:
2009
|
|
17
|
Chen HY, Ge Z, Wu YJ, Wu LY, Sun M, Tian
T, Qiou HR, Liu P and Li JY: Immunophenotypic analysis of
Philadelphia chromosome positive acute lymphoblastic leukaemia in
adults. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 18:714–717. 2010.(In
Chinese). PubMed/NCBI
|
|
18
|
Miao Y, Fan L, Wu YJ, Xia Y, Qiao C, Wang
Y, Wang L, Hong M, Zhu HY, Xu W and Li JY: Low expression of CD200
predicts shorter time-to-treatment in chronic lymphocytic leukemia.
Oncotarget. 7:13551–13562. 2016.PubMed/NCBI
|
|
19
|
Van Vlierberghe P, Palomero T, Khiabanian
H, Van der Meulen J, Castillo M, Van Roy N, De Moerloose B,
Philippé J, González-García S, Toribio ML, et al: PHF6 mutations in
T-cell acute lymphoblastic leukemia. Nat Genet. 42:338–342. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ferguson SM and De Camilli P: Dynamin, a
membrane-remodelling GTPase. Nat Rev Mol Cell Biol. 13:75–88.
2012.PubMed/NCBI
|
|
21
|
Bitoun M, Maugenre S, Jeannet PY, Lacène
E, Ferrer X, Laforêt P, Martin JJ, Laporte J, Lochmüller H, Beggs
AH, et al: Mutations in dynamin 2 cause dominant centronuclear
myopathy. Nat Genet. 37:1207–1209. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Aidaralieva NJ, Kamino K, Kimura R,
Yamamoto M, Morihara T, Kazui H, Hashimoto R, Tanaka T, Kudo T,
Kida T, et al: Dynamin 2 gene is a novel susceptibility gene for
late-onset Alzheimer disease in non-APOE-epsilon4 carriers. J Hum
Genet. 53:296–302. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Koutsopoulos OS, Kretz C, Weller CM, Roux
A, Mojzisova H, Böhm J, Koch C, Toussaint A, Heckel E, Stemkens D,
et al: Dynamin 2 homozygous mutation in humans with a lethal
congenital syndrome. Eur J Hum Genet. 21:637–642. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nagai K, Kohno T, Chen YX, Tsushima H,
Mori H, Nakamura H, Jinnai I, Matsuo T, Kuriyama K, Tomonaga M and
Bennett JM: Diagnostic criteria for hypocellular acute leukemia: A
clinical entity distinct from overt acute leukemia and
myelodysplastic syndrome. Leuk Res. 20:563–574. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hu X, Fu W, Wang L, Gao L, Lü S, Xi H, Qiu
H, Chen L, Chen J, Ni X, et al: HAG regimen improves survival in
adult patients with hypocellular acute myeloid leukemia.
Oncotarget. 7:3623–3634. 2016.PubMed/NCBI
|
|
26
|
Chamary JV, Parmley JL and Hurst LD:
Hearing silence: Non-neutral evolution at synonymous sites in
mammals. Nat Rev Genet. 7:98–108. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Goymer P: Synonymous mutations break their
silence. Nat Rev Genet. 8:922007. View
Article : Google Scholar
|
|
28
|
Zhou T, Ko EA, Gu W, Lim I, Bang H and Ko
JH: Non-silent story on synonymous sites in voltage-gated ion
channel genes. PLoS One. 7:e485412012. View Article : Google Scholar : PubMed/NCBI
|
